Oct 19

The Unconscious Conversation

The ability to communicate well is every business leader’s primary tool. Why do some speakers always win over the audience, while others fail... View Webinar

The ability to communicate well is every business leader’s primary tool. Why do some speakers always win over the audience, while others fail to connect? Most speakers get all the words right, but make little or no impact upon their audience. Those speakers fail because they are unaware of the “Unconscious Conversation.”

View Webinar

Oct 04

The Unconscious Conversation

The ability to communicate well is every business leader’s primary tool. Why do some speakers always win over the audience, while others fail... View Webinar

The ability to communicate well is every business leader’s primary tool. Why do some speakers always win over the audience, while others fail to connect?

View Webinar

The emotional power President Obama drew upon is a connection all great speakers seek to make with their audience. It’s a connection that occurs only when the audience can sense the speaker’s words, because those words are genuinely connected to personal values and shared experience. That kind of content is what I like to call “shared context.” It only happens when the words are rooted in character and they are delivered with passion and conviction.

Read More

Introduction On June 1, FDA issued a draft guidance, Evaluation and Reporting of Age, Race and Ethnicity Data in Medical Device Clinical Studies, which provides recommendations for the evaluation and reporting of age, race, and ethnicity data in medical device clinical studies.  This draft guidance has important implications for trial…

Read More

Jun 15

Truth & Consequences: Pricing, Patient Access and What’s Next for Today’s BioPharm

Today’s exciting medical innovations should be shining moments for biopharma. Instead, companies are increasingly being tarnished by a... View Webinar

Today’s exciting medical innovations should be shining moments for biopharma. Instead, companies are increasingly being tarnished by a backlash over prices. Increased scrutiny means the old way of justifying a therapy’s price is obsolete. Influential stakeholders are demanding collaboration and transparency to maximize patient access.

View Webinar

“60 Minutes” stories are morality plays. Good vs. Evil. The hero is the correspondent, who brings the story to climax with what Mike Wallace called, the “best question. One they don’t know is coming and I already have the answer.” They call that moment, the “Gotcha.”

When executives are deciding whether to accept interviews with shows like “60 Minutes,” they need to understand the gestalt of these shows – and learn how to survive and even excel on them.

Read More

May 18

Preparing Early for a Successful FDA Advisory Committee or Device Panel Meeting

Good data alone are no longer enough to win approval. In today’s environment, it is critical to prepare a clear, credible and engaging... View Webinar

Good data alone are no longer enough to win approval. In today’s environment, it is critical to prepare a clear, credible and engaging presentation and to start the preparation process early.

View Webinar

May 16

Panel Meeting Strategies: A Critical Look at the New Draft Guidance

We will: understand the panel process, detail recent draft guidance impacts panel preparation, assess opportunities to enhance the likelihood of... View Webinar

We will: understand the panel process, detail recent draft guidance impacts panel preparation, assess opportunities to enhance the likelihood of success before you submit your PMA, and understand success panel preparation steps.

View Webinar

As all of our work becomes increasingly global, it is interesting to note the significant social, cultural, language and other differences that make message development and communications training for different countries more challenging than ever. This is particularly true when the messages on a product or issue have to be consistent across a global organization, but at the same time, resonate with – and not offend — audiences in specific regions.

Read More